相关实验视频
Updated: Jan 15, 2026
07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
9.3K
奥马利祖马布可以使患者对毒素免疫疗法有过敏反应的患者减轻蜜蜂毒的敏感性
Kris Capper1, Benjamin McGettigan2, Cate Willis1
1Fiona Stanley Hospital, Perth, Western Australia, Australia.
The journal of allergy and clinical immunology. In practice
|October 10, 2025
概括
奥马利祖马布可以帮助在蜜蜂毒液免疫疗法 (VIT) 期间出现严重过敏反应的患者. 这种抗IgE抗体可能会提高耐受性,并允许成功完成VIT,特别是在半冲动协议下.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 毒液免疫疗法 (VIT) 是蜜蜂毒液过敏的唯一治疗方法.
- 在VIT期间可能发生严重的过敏反应 (SAR),限制其使用.
- 抗IgE抗体奥马利祖马布 (Omalizumab) 显示有可能改善VIT耐受性,但数据很少.
研究的目的:
- 评估奥马利祖马布作为蜂蜜VIT的辅助药物的疗效.
- 为了确定在VIT期间需要奥马利祖马布的预测因素.
- 为了指导选择最佳的VIT协议.
主要方法:
- 对接受蜜蜂VIT (2015-2024) 的成年患者的回顾性图表审查.
- 分析基线特征,生物标志物,治疗方案和临床结果.
- 在VIT期间对Omalizumab在管理SARs中的作用的评估.
主要成果:
- 在354名VIT患者中,57%的患者经历了SAR;36%的患者接受了奥马利祖马布.
- 奥马利祖马布使用的预测因素包括严重的刺痛过敏反应,喘和基础酸酶升高.
- 在升级期间使用奥马利祖马布的患者中,有63%的患者实现了无支持的维护,成功率为73% (不包括放弃).
结论:
- 在标准VIT期间,Omalizumab是患有复发SARs的患者的可行选择.
- 一个半冲动的协议与先前的奥马利祖马布加载是耐受和有效的.
- 对奥马利祖马布在VIT中的作用进行进一步研究是有必要的.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
02:06Allergic Reactions
32.0K
Overview
32.0K
00:42Cross-reactivity
32.8K
Overview
32.8K
01:27Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
01:19Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
01:10Antibody Structure
65.3K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
65.3K